Characterization of proteinase-activated receptor 2 signalling and expression in rat hippocampal neurons and astrocytes

[1]  M. Hollenberg,et al.  Proteinase-Activated Receptor-2 Induction by Neuroinflammation Prevents Neuronal Death during HIV Infection1 , 2005, The Journal of Immunology.

[2]  Takeshi Hayashi,et al.  Deficiency of PAR-2 Gene Increases Acute Focal Ischemic Brain Injury , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  S. Traynelis,et al.  Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes. , 2003, Molecular pharmacology.

[4]  D. Brat,et al.  The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  B. Citron,et al.  Persistent Protease-activated Receptor 4 Signaling Mediates Thrombin-induced Microglial Activation* , 2003, Journal of Biological Chemistry.

[6]  N. Emptage,et al.  The α-Latrotoxin Mutant LTXN4C Enhances Spontaneous and Evoked Transmitter Release in CA3 Pyramidal Neurons , 2003, The Journal of Neuroscience.

[7]  A. Rao,et al.  Role of Gαq and phospholipase C‐β2 in human platelets activation by thrombin receptors PAR1 and PAR4: studies in human platelets deficient in Gαq and phospholipase C‐β2 , 2003 .

[8]  M. Hollenberg,et al.  Up-Regulation of Proteinase-Activated Receptor 1 Expression in Astrocytes During HIV Encephalitis1 , 2003, The Journal of Immunology.

[9]  A. Irving,et al.  Leptin inhibits epileptiform‐like activity in rat hippocampal neurones via PI 3‐kinase‐driven activation of BK channels , 2002, The Journal of physiology.

[10]  J. Wood,et al.  Serine proteases excite myenteric neurons through protease-activated receptors in guinea pig small intestine. , 2002, Gastroenterology.

[11]  K. Reymann,et al.  Increase of prothrombin-mRNA after global cerebral ischemia in rats, with constant expression of protease nexin-1 and protease-activated receptors , 2002, Neuroscience Letters.

[12]  B. Guiard,et al.  Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats. , 2002, Gastroenterology.

[13]  G. Reiser,et al.  Four subtypes of protease‐activated receptors, co‐expressed in rat astrocytes, evoke different physiological signaling , 2002, Glia.

[14]  P. Pasricha,et al.  The Proteinase-Activated Receptor 2 Is Involved in Nociception , 2001, The Journal of Neuroscience.

[15]  P. Thompson,et al.  Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma. , 2001, The Journal of allergy and clinical immunology.

[16]  M. Krug,et al.  Four different types of protease‐activated receptors are widely expressed in the brain and are up‐regulated in hippocampus by severe ischemia , 2001, The European journal of neuroscience.

[17]  A. Basbaum,et al.  Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway , 2001, Nature Medicine.

[18]  G. D. Hunter,et al.  Proteinase-activated receptors. , 2001, Pharmacological reviews.

[19]  Sharon Anavi-Goffer,et al.  Agonist-Induced Internalization and Trafficking of Cannabinoid CB1 Receptors in Hippocampal Neurons , 2001, The Journal of Neuroscience.

[20]  D. Armstrong,et al.  Stable Activation of Single Ca2+ Release-activated Ca2+ Channels in Divalent Cation-free Solutions* , 2001, The Journal of Biological Chemistry.

[21]  G. Collingridge,et al.  Role of Ca2+ Stores in Metabotropicl-Glutamate Receptor-Mediated Supralinear Ca2+Signaling in Rat Hippocampal Neurons , 2000, The Journal of Neuroscience.

[22]  S. Coughlin,et al.  Thrombin signalling and protease-activated receptors , 2000, Nature.

[23]  E. Mackie,et al.  Expression of protease‐activated receptor‐2 during embryonic development , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.

[24]  S. Traynelis,et al.  Potentiation of NMDA Receptor Function by the Serine Protease Thrombin , 2000, The Journal of Neuroscience.

[25]  R. Mullins,et al.  β-Arrestin–Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2 , 2000, The Journal of cell biology.

[26]  N. Bunnett,et al.  Trafficking of Proteinase-activated Receptor-2 and β-Arrestin-1 Tagged with Green Fluorescent Protein , 1999, The Journal of Biological Chemistry.

[27]  M. Hollenberg,et al.  Proteinase-activated receptor 4 (PAR4): action of PAR4-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR1 and PAR2. , 1999, Canadian journal of physiology and pharmacology.

[28]  M. Carr,et al.  A protective role for protease-activated receptors in the airways , 1999, Nature.

[29]  Robert V Farese,et al.  A dual thrombin receptor system for platelet activation , 1998, Nature.

[30]  Scott R. Presnell,et al.  Cloning and characterization of human protease-activated receptor 4. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. Reiser,et al.  Co-existence of two types of [Ca2+]i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells , 1998, Neuroscience.

[32]  R. Vejsada,et al.  Changes in the expression of protease‐activated receptor 1 and protease nexin‐1 mRNA during rat nervous system development and after nerve lesion , 1998, The European journal of neuroscience.

[33]  S. M. Baker,et al.  Characterization of Protease-activated Receptor-2 Immunoreactivity in Normal Human Tissues , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[34]  M. D'Andrea,et al.  Protease‐Activated Receptor‐2 (PAR‐2) Is Present in the Rat Hippocampus and Is Associated with Neurodegeneration , 1997, Journal of neurochemistry.

[35]  M. Hollenberg,et al.  Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. , 1997, Canadian journal of physiology and pharmacology.

[36]  S. Coughlin,et al.  Protease-activated receptor 3 is a second thrombin receptor in humans , 1997, Nature.

[37]  D. Payan,et al.  Mechanisms of Desensitization and Resensitization of Proteinase-activated Receptor-2* , 1996, The Journal of Biological Chemistry.

[38]  V. Ramakrishnan,et al.  The Proteinase-activated Receptor 2 Is Induced by Inflammatory Mediators in Human Endothelial Cells , 1996, The Journal of Biological Chemistry.

[39]  B. Strömbeck,et al.  Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. , 1995, European journal of biochemistry.

[40]  M. Hollenberg,et al.  Detection of functional receptors for the proteinase-activated-receptor-2-activating polypeptide, SLIGRL-NH2, in rat vascular and gastric smooth muscle. , 1995, Canadian journal of physiology and pharmacology.

[41]  C. Cotman,et al.  Decreases in protease nexins in Alzheimer's disease brain , 1995, Neurobiology of Aging.

[42]  D. Cunningham,et al.  Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[43]  C. Wahlestedt,et al.  Molecular cloning of a potential proteinase activated receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Williamson,et al.  G protein coupling to the thrombin receptor in Chinese hamster lung fibroblasts. , 1994, The Journal of biological chemistry.

[45]  G. Schultz,et al.  G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[46]  J. Chen,et al.  Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases. , 1994, The Journal of biological chemistry.

[47]  S. Coughlin,et al.  The cloned platelet thrombin receptor couples to at least two distinct effectors to stimulate phosphoinositide hydrolysis and inhibit adenylyl cyclase. , 1992, The Journal of biological chemistry.

[48]  V. Wheaton,et al.  Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. , 1992, The Journal of biological chemistry.

[49]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[50]  M. Poncz,et al.  Receptor and G protein-mediated responses to thrombin in HEL cells. , 1991, The Journal of biological chemistry.

[51]  R. Nissenson,et al.  Thrombin stimulates inositol phosphate production and intracellular free calcium by a pertussis toxin-insensitive mechanism in osteosarcoma cells. , 1990, Endocrinology.

[52]  Andreas Beck,et al.  Calcium release from intracellular stores in rodent astrocytes and neurons in situ. , 2004, Cell calcium.

[53]  M. Hollenberg,et al.  The role of the C-terminal tail in protease-activated receptor-2-mediated Ca2+ signalling, proline-rich tyrosine kinase-2 activation, and mitogen-activated protein kinase activity. , 2004, Cellular signalling.

[54]  T. Kohout,et al.  Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization. , 2003, Molecular pharmacology.

[55]  G. D. Hunter,et al.  Essential role for proteinase-activated receptor-2 in arthritis. , 2003, The Journal of clinical investigation.

[56]  M. Hollenberg,et al.  Proteinase-activated receptor 2: differential activation of the receptor by tethered ligand and soluble peptide analogs. , 2002, The Journal of pharmacology and experimental therapeutics.

[57]  V. Bindokas,et al.  Molecular components of tolerance to opiates in single hippocampal neurons. , 2002, Molecular pharmacology.

[58]  M. Hollenberg,et al.  Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands. , 1999, The Journal of pharmacology and experimental therapeutics.